174 related articles for article (PubMed ID: 38243011)
21. Preoperative Evaluation of the ADNEX Model for the Prediction of the Ovarian Cancer Risk of Adnexal Masses at Siriraj Hospital.
Poonyakanok V; Tanmahasamut P; Jaishuen A; Wongwananuruk T; Asumpinwong C; Panichyawat N; Chantrapanichkul P
Gynecol Obstet Invest; 2021; 86(1-2):132-138. PubMed ID: 33596584
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the risk of malignancy in adnexal masses: validation of O-RADS and comparison with ADNEX model, SA, and RMI.
Wang R; Yang Z
Ginekol Pol; 2023; 94(10):799-806. PubMed ID: 36929789
[TBL] [Abstract][Full Text] [Related]
23. ADNEX risk prediction model for diagnosis of ovarian cancer: systematic review and meta-analysis of external validation studies.
Barreñada L; Ledger A; Dhiman P; Collins G; Wynants L; Verbakel JY; Timmerman D; Valentin L; Van Calster B
BMJ Med; 2024; 3(1):e000817. PubMed ID: 38375077
[TBL] [Abstract][Full Text] [Related]
24. Prospective comparative trial comparing O-RADS, IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer.
Poonyakanok V; Tanmahasamut P; Jaishuen A
J Obstet Gynaecol Res; 2023 May; 49(5):1412-1417. PubMed ID: 36895122
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study.
Sayasneh A; Ferrara L; De Cock B; Saso S; Al-Memar M; Johnson S; Kaijser J; Carvalho J; Husicka R; Smith A; Stalder C; Blanco MC; Ettore G; Van Calster B; Timmerman D; Bourne T
Br J Cancer; 2016 Aug; 115(5):542-8. PubMed ID: 27482647
[TBL] [Abstract][Full Text] [Related]
26. The Optimal Cut-Off Point of the ADNEX Model for the Prediction of the Ovarian Cancer Risk.
Lam Huong L; Thi Phuong Dung N; Hoang Lam V; Tran Thao Nguyen N; Minh Tam L; Vu Quoc Huy N
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2713-2718. PubMed ID: 36037125
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
[TBL] [Abstract][Full Text] [Related]
28. External validation of the MR imaging scoring system for the management of adnexal masses.
Ruiz M; Labauge P; Louboutin A; Limot O; Fauconnier A; Huchon C
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():115-9. PubMed ID: 27583370
[TBL] [Abstract][Full Text] [Related]
29. Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.
Van Gorp T; Veldman J; Van Calster B; Cadron I; Leunen K; Amant F; Timmerman D; Vergote I
Eur J Cancer; 2012 Jul; 48(11):1649-56. PubMed ID: 22226481
[TBL] [Abstract][Full Text] [Related]
30. External Validation of O-RADS US Risk Stratification and Management System.
Hack K; Gandhi N; Bouchard-Fortier G; Chawla TP; Ferguson SE; Li S; Kahn D; Tyrrell PN; Glanc P
Radiology; 2022 Jul; 304(1):114-120. PubMed ID: 35438559
[TBL] [Abstract][Full Text] [Related]
31. Assessment of different NEoplasias in the adneXa model for differentiation of benign and malignant adnexal masses in Korean women.
Nam G; Lee SR; Jeong K; Kim SH; Moon HS; Chae HD
Obstet Gynecol Sci; 2021 May; 64(3):293-299. PubMed ID: 33593045
[TBL] [Abstract][Full Text] [Related]
32. Sonographic Assessment of Complex Ultrasound Morphology Adnexal Tumors in Pregnant Women with the Use of IOTA Simple Rules Risk and ADNEX Scoring Systems.
Czekierdowski A; Stachowicz N; Smoleń A; Kluz T; Łoziński T; Miturski A; Kraczkowski J
Diagnostics (Basel); 2021 Feb; 11(3):. PubMed ID: 33671023
[TBL] [Abstract][Full Text] [Related]
33. A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.
Kaijser J; Van Gorp T; Van Hoorde K; Van Holsbeke C; Sayasneh A; Vergote I; Bourne T; Timmerman D; Van Calster B
Gynecol Oncol; 2013 May; 129(2):377-83. PubMed ID: 23360924
[TBL] [Abstract][Full Text] [Related]
34. Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography?
Kaijser J; Van Gorp T; Smet ME; Van Holsbeke C; Sayasneh A; Epstein E; Bourne T; Vergote I; Van Calster B; Timmerman D
Ultrasound Obstet Gynecol; 2014 Jan; 43(1):89-97. PubMed ID: 23828371
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the predictive performance of risk of malignancy indexes 1-4, HE4 and risk of malignancy algorithm in the triage of adnexal masses.
Hada A; Han LP; Chen Y; Hu QH; Yuan Y; Liu L
J Ovarian Res; 2020 Apr; 13(1):46. PubMed ID: 32334618
[TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance scoring system for assessment of adnexal masses: added value of diffusion-weighted imaging including apparent diffusion coefficient map.
Hottat NA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
Ultrasound Obstet Gynecol; 2021 Mar; 57(3):478-487. PubMed ID: 32438461
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses.
Yang Y; Ju H; Huang Y
Eur J Radiol; 2023 Aug; 165():110926. PubMed ID: 37418798
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Accuracies of the Ultrasound and Magnetic Resonance Imaging ADNEX Scoring Systems For Ovarian Adnexal Mass: Systematic Review and Meta-Analysis.
Cui L; Xu H; Zhang Y
Acad Radiol; 2022 Jun; 29(6):897-908. PubMed ID: 34217614
[TBL] [Abstract][Full Text] [Related]
39. Comparison of CA 125 alone and risk of ovarian malignancy algorithm (ROMA) in patients with adnexal mass: A multicenter study.
Choi HJ; Lee YY; Sohn I; Kim YM; Kim JW; Kang S; Kim BG
Curr Probl Cancer; 2020 Apr; 44(2):100508. PubMed ID: 31708114
[TBL] [Abstract][Full Text] [Related]
40. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
Li F; Tie R; Chang K; Wang F; Deng S; Lu W; Yu L; Chen M
BMC Cancer; 2012 Jun; 12():258. PubMed ID: 22712526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
